世界のアナモレリン市場予測（～2028年）：純度≥98％、純度≥99％

• 英文タイトル：Global Anamorelin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E0543 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

アナモレリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のアナモレリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 アナモレリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・純度≥98％、純度≥99％ 用途別セグメントは次のように区分されます。 ・食欲不振症治療、医学研究（腫瘍）、その他 世界のアナモレリン市場の主要な市場プレーヤーは以下のとおりです。 ・Chengdu Climb Pharmaceutical、Chengda Pharmaceuticals、Hunan Huateng Pharmaceutical、JieJie Group、Helsinn、AlchemyPharm 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、アナモレリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なアナモレリンメーカーの企業概要、2019年～2022年までのアナモレリンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なアナモレリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別アナモレリンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのアナモレリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアナモレリン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびアナモレリンの産業チェーンを掲載しています。 ・第13、14、15章では、アナモレリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Chengdu Climb Pharmaceutical、Chengda Pharmaceuticals、Hunan Huateng Pharmaceutical、JieJie Group、Helsinn、AlchemyPharm ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：純度≥98％、純度≥99％ ・用途別分析2017年-2028年：食欲不振症治療、医学研究（腫瘍）、その他 ・アナモレリンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・アナモレリンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・アナモレリンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アナモレリンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・アナモレリンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Anamorelin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anamorelin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Anorexia Treatment accounting for % of the Anamorelin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity ≥98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anamorelin include Chengdu Climb Pharmaceutical, Chengda Pharmaceuticals, Hunan Huateng Pharmaceutical, JieJie Group, and Helsinn, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anamorelin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ≥98%
Purity ≥99%
Market segment by Application can be divided into
Anorexia Treatment
Medical Research (Oncology)
Other
The key market players for global Anamorelin market are listed below:
Chengdu Climb Pharmaceutical
Chengda Pharmaceuticals
Hunan Huateng Pharmaceutical
JieJie Group
Helsinn
AlchemyPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anamorelin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anamorelin, with price, sales, revenue and global market share of Anamorelin from 2019 to 2022.
Chapter 3, the Anamorelin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anamorelin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anamorelin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anamorelin.
Chapter 13, 14, and 15, to describe Anamorelin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Anamorelin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anamorelin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Market Analysis by Application
1.3.1 Overview: Global Anamorelin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anorexia Treatment
1.3.3 Medical Research (Oncology)
1.3.4 Other
1.4 Global Anamorelin Market Size & Forecast
1.4.1 Global Anamorelin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anamorelin Sales in Volume (2017-2028)
1.4.3 Global Anamorelin Price (2017-2028)
1.5 Global Anamorelin Production Capacity Analysis
1.5.1 Global Anamorelin Total Production Capacity (2017-2028)
1.5.2 Global Anamorelin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anamorelin Market Drivers
1.6.2 Anamorelin Market Restraints
1.6.3 Anamorelin Trends Analysis
2 Manufacturers Profiles
2.1 Chengdu Climb Pharmaceutical
2.1.1 Chengdu Climb Pharmaceutical Details
2.1.2 Chengdu Climb Pharmaceutical Major Business
2.1.3 Chengdu Climb Pharmaceutical Anamorelin Product and Services
2.1.4 Chengdu Climb Pharmaceutical Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Chengda Pharmaceuticals
2.2.1 Chengda Pharmaceuticals Details
2.2.2 Chengda Pharmaceuticals Major Business
2.2.3 Chengda Pharmaceuticals Anamorelin Product and Services
2.2.4 Chengda Pharmaceuticals Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hunan Huateng Pharmaceutical
2.3.1 Hunan Huateng Pharmaceutical Details
2.3.2 Hunan Huateng Pharmaceutical Major Business
2.3.3 Hunan Huateng Pharmaceutical Anamorelin Product and Services
2.3.4 Hunan Huateng Pharmaceutical Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 JieJie Group
2.4.1 JieJie Group Details
2.4.2 JieJie Group Major Business
2.4.3 JieJie Group Anamorelin Product and Services
2.4.4 JieJie Group Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Helsinn
2.5.1 Helsinn Details
2.5.2 Helsinn Major Business
2.5.3 Helsinn Anamorelin Product and Services
2.5.4 Helsinn Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AlchemyPharm
2.6.1 AlchemyPharm Details
2.6.2 AlchemyPharm Major Business
2.6.3 AlchemyPharm Anamorelin Product and Services
2.6.4 AlchemyPharm Anamorelin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anamorelin Breakdown Data by Manufacturer
3.1 Global Anamorelin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anamorelin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anamorelin
3.4 Market Concentration Rate
3.4.1 Top 3 Anamorelin Manufacturer Market Share in 2021
3.4.2 Top 6 Anamorelin Manufacturer Market Share in 2021
3.5 Global Anamorelin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anamorelin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anamorelin Market Size by Region
4.1.1 Global Anamorelin Sales in Volume by Region (2017-2028)
4.1.2 Global Anamorelin Revenue by Region (2017-2028)
4.2 North America Anamorelin Revenue (2017-2028)
4.3 Europe Anamorelin Revenue (2017-2028)
4.4 Asia-Pacific Anamorelin Revenue (2017-2028)
4.5 South America Anamorelin Revenue (2017-2028)
4.6 Middle East and Africa Anamorelin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anamorelin Sales in Volume by Type (2017-2028)
5.2 Global Anamorelin Revenue by Type (2017-2028)
5.3 Global Anamorelin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anamorelin Sales in Volume by Application (2017-2028)
6.2 Global Anamorelin Revenue by Application (2017-2028)
6.3 Global Anamorelin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anamorelin Sales by Type (2017-2028)
7.2 North America Anamorelin Sales by Application (2017-2028)
7.3 North America Anamorelin Market Size by Country
7.3.1 North America Anamorelin Sales in Volume by Country (2017-2028)
7.3.2 North America Anamorelin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anamorelin Sales by Type (2017-2028)
8.2 Europe Anamorelin Sales by Application (2017-2028)
8.3 Europe Anamorelin Market Size by Country
8.3.1 Europe Anamorelin Sales in Volume by Country (2017-2028)
8.3.2 Europe Anamorelin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anamorelin Sales by Type (2017-2028)
9.2 Asia-Pacific Anamorelin Sales by Application (2017-2028)
9.3 Asia-Pacific Anamorelin Market Size by Region
9.3.1 Asia-Pacific Anamorelin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anamorelin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anamorelin Sales by Type (2017-2028)
10.2 South America Anamorelin Sales by Application (2017-2028)
10.3 South America Anamorelin Market Size by Country
10.3.1 South America Anamorelin Sales in Volume by Country (2017-2028)
10.3.2 South America Anamorelin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anamorelin Sales by Type (2017-2028)
11.2 Middle East & Africa Anamorelin Sales by Application (2017-2028)
11.3 Middle East & Africa Anamorelin Market Size by Country
11.3.1 Middle East & Africa Anamorelin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anamorelin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anamorelin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anamorelin
12.3 Anamorelin Production Process
12.4 Anamorelin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anamorelin Typical Distributors
13.3 Anamorelin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---